Professional Marketing briefs

Share this article:
Shire is sponsoring six inflammatory bowel disease (IBD) fellowships that “will provide a year of training in the management of IBD to physicians who recently completed a fellowship in gastroenterology.” The fellowships will be housed at top medical institutions including Cedars-Sinai in LA, Cleveland Clinic, Mayo Clinic, Mount Sinai, the University of California San Francisco and University of Chicago Medical Center.

The trailer for Love and Other Drugs is out and early reviews suggest few side effects for pharmas. The movie, opening in November, is an adaptation of Hard Sell: The Evolution of a Viagra Salesman, which skewered sales reps as being lazy and docs as being greedy. The big screen version seems to have jettisoned much of the book's hard-edged humor about industry marketing practices and work ethics for the softer focus befitting a romantic comedy starring Jake Gyllenhaal and Anne Hathaway.

Procter & Gamble signed on to co-promote Somaxon Pharmaceuticals' sleep aid Silenor. The companies will field a sales force of 215 for the drug, targeting 35,000 high prescribers and 25,000 pharmacies. P&G will be paid fees and sales-based royalties and gets dibs on development of an OTC version.
Share this article:
You must be a registered member of MMM to post a comment.

Next Article in Features

Email Newsletters


Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.

More in Features

Read the complete September 2014 Digital Edition

Read the complete September 2014 Digital Edition

Click the above link to access the complete Digital Edition of the August 2014 issue of MM&M, with all text, charts and pictures.

Medical marketing needs mainstream Mad Men

Medical marketing needs mainstream Mad Men

Agencies must generate emotional resonance with the target audience, not unlike Apple, Pepsi or Nike

Are discounts cutting out co-pays?

GSK's decision to cut Advair's price spurred some PBMs to put it back on formulary. Will drugmaker discounts diminish the need for loyalty programs? How can these programs stay relevant beyond giving co-pay assistance?